Liraglutide for Type 2 diabetes and obesity: a 2015 update.

Iepsen, Eva Winning

Liraglutide for Type 2 diabetes and obesity: a 2015 update. [electronic resource] - Expert review of cardiovascular therapy 2015 - 753-67 p. digital

Publication Type: Journal Article; Review

1744-8344

10.1586/14779072.2015.1054810 doi


Appetite Depressants--pharmacology
Diabetes Mellitus, Type 2--drug therapy
Glucagon-Like Peptide 1--physiology
Humans
Hypoglycemic Agents--pharmacokinetics
Liraglutide--pharmacokinetics
Obesity--drug therapy
Glucagon-Like Peptide-1 Receptor Agonists